Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Markerless Pancreatic Tumor Target Localization Enabled By Deep Learning.

Zhao W, Shen L, Han B, Yang Y, Cheng K, Toesca DAS, Koong AC, Chang DT, Xing L.

Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):432-439. doi: 10.1016/j.ijrobp.2019.05.071. Epub 2019 Jun 13.

PMID:
31201892
2.

Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.

Koenig JL, Toesca DAS, Harris JP, Tsai CJ, Haraldsdottir S, Lin AY, Pollom EL, Chang DT.

Am J Clin Oncol. 2019 Jul;42(7):573-580. doi: 10.1097/COC.0000000000000554.

PMID:
31166206
3.

Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.

Toesca DAS, Jeffrey RB, von Eyben R, Pollom EL, Poullos PD, Poultsides GA, Fisher GA Jr, Visser BC, Koong AC, Chang DT.

Pancreas. 2019 May/Jun;48(5):622-628. doi: 10.1097/MPA.0000000000001314.

4.

Neural Networks for Deep Radiotherapy Dose Analysis and Prediction of Liver SBRT Outcomes.

Ibragimov B, Toesca DAS, Yuan Y, Koong AC, Chang DT, Xing L.

IEEE J Biomed Health Inform. 2019 Sep;23(5):1821-1833. doi: 10.1109/JBHI.2019.2904078. Epub 2019 Mar 11.

PMID:
30869633
5.

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity.

Toesca DAS, Koong AJ, von Eyben R, Koong AC, Chang DT.

Adv Radiat Oncol. 2018 May 24;3(4):621-629. doi: 10.1016/j.adro.2018.05.006. eCollection 2018 Oct-Dec.

6.

Clinical Case Panel: Treatment Alternatives for Inoperable Hepatocellular Carcinoma.

Toesca DAS, Barry A, Sapisochin G, Beecroft R, Dawson L, Owen D, Mouli S, Lewandowski R, Salem R, Chang DT.

Semin Radiat Oncol. 2018 Oct;28(4):295-308. doi: 10.1016/j.semradonc.2018.08.001. Review.

PMID:
30309640
7.

Management of Borderline Resectable Pancreatic Cancer.

Toesca DAS, Koong AJ, Poultsides GA, Visser BC, Haraldsdottir S, Koong AC, Chang DT.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1155-1174. doi: 10.1016/j.ijrobp.2017.12.287. Review.

PMID:
29722658
8.

A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation.

Yang Z, Zhang J, Jiang D, Khatri P, Solow-Cordero DE, Toesca DAS, Koumenis C, Denko NC, Giaccia AJ, Le QT, Koong AC.

Mol Cancer Res. 2018 May;16(5):745-753. doi: 10.1158/1541-7786.MCR-17-0307. Epub 2018 Feb 9.

9.

Strategies for prediction and mitigation of radiation-induced liver toxicity.

Toesca DAS, Ibragimov B, Koong AJ, Xing L, Koong AC, Chang DT.

J Radiat Res. 2018 Mar 1;59(suppl_1):i40-i49. doi: 10.1093/jrr/rrx104.

10.

Nonoperative Management of Rectal Cancer: A Modern Perspective.

Qian Y, Chin AL, Toesca DAS, Koong AC, Chang DT.

Oncology (Williston Park). 2017 Oct 15;31(10):e13-e22. Review.

11.

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.

Koong AJ, Toesca DAS, von Eyben R, Pollom EL, Chang DT.

Adv Radiat Oncol. 2017 Jan 18;2(1):27-36. doi: 10.1016/j.adro.2017.01.003. eCollection 2017 Jan-Mar.

12.

Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.

Toesca DAS, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT.

Pract Radiat Oncol. 2017 May - Jun;7(3):173-182. doi: 10.1016/j.prro.2016.10.003. Epub 2016 Oct 17.

PMID:
28343896
13.

Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.

Toesca DA, Pollom EL, Poullos PD, Flynt L, Cui Y, Quon A, von Eyben R, Koong AC, Chang DT.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):120-125. doi: 10.1016/j.prro.2016.09.002. Epub 2016 Sep 7.

PMID:
28274396
14.

Central liver toxicity after SBRT: An expanded analysis and predictive nomogram.

Toesca DA, Osmundson EC, Eyben RV, Shaffer JL, Lu P, Koong AC, Chang DT.

Radiother Oncol. 2017 Jan;122(1):130-136. doi: 10.1016/j.radonc.2016.10.024. Epub 2016 Nov 16.

PMID:
27865544

Supplemental Content

Loading ...
Support Center